(Q81381423)
Statements
Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease (English)
Okamoto M
Okano A
Akamatsu S
Ashihara E
Inaba T
Takenaka H
Katoh N
Kishimoto S
scientific article published on 01 January 2006